Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning the Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus, 34968-34969 [2011-14801]
Download as PDF
34968
Federal Register / Vol. 76, No. 115 / Wednesday, June 15, 2011 / Notices
96814–4700; phone (808) 944–2200; fax
(808) 973–2941.
Written comments or requests for a
public hearing on this request should be
submitted to the Chief, Permits,
Conservation and Education Division, at
the address listed above. Comments may
also be submitted by facsimile to (301)
713–0376, or by e-mail to
NMFS.Pr1Comments@noaa.gov. Please
include the File No. in the subject line
of the e-mail comment.
Those individuals requesting a
hearing should set forth the specific
reasons why a hearing on this particular
modification request would be
appropriate.
FOR FURTHER INFORMATION CONTACT:
Amy Hapeman or Kristy Beard, (301)
713–2289.
The
subject modification to Permit No.
10027, issued on July 30, 2008 (73 FR
44224), is requested under the authority
of the Endangered Species Act of 1973,
as amended (16 U.S.C. 1531 et seq.) and
the regulations governing the taking,
importing, and exporting of endangered
and threatened species (50 CFR 222–
226).
The permit currently authorizes the
permit holder to study the population
biology and connectivity of green
(Chelonia mydas) and hawksbill
(Eretmochelys imbricata) sea turtles
focusing on distribution and abundance,
ecology, health, and threats to sea
turtles at the Palmyra Atoll in the
Pacific Ocean. The permit holder
requests a modification to their existing
permit to increase the number of green
sea turtles taken annually from 100 to
250 turtles per year. Of the total 250
green sea turtles, researchers request to
increase the number tagged with sonic
transmitters from 30 to 40 turtles
annually. The modification is needed to
accommodate higher than anticipated
capture rates and an increase in capture
efforts. These data will help determine
if temporal, stage-specific, or sexspecific movement patterns exist for the
population of sea turtles at Palmyra. The
modified permit would expire July 31,
2013.
jlentini on DSK4TPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Dated: June 10, 2011.
Tammy C. Adams,
Acting Chief, Permits, Conservation and
Education Division, Office of Protected
Resources, National Marine Fisheries Service.
[FR Doc. 2011–14857 Filed 6–14–11; 8:45 am]
BILLING CODE 3510–22–P
VerDate Mar<15>2010
16:42 Jun 14, 2011
Jkt 223001
Department of the Army
Intent to Grant an Exclusive License of
U.S. Government-Owned Inventions
April 20, 2011. The United States
Government, as represented by the
Secretary of the Army, has rights to this
invention.
ADDRESSES:
DEPARTMENT OF DEFENSE
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
In accordance with 35 U.S.C.
209(e), and 37 CFR 404.7(a)(1)(i) and 37
CFR 404.7(b)(1)(i), announcement is
made of the intent to grant an exclusive,
revocable license to the invention
claimed in the PCT/US2009/060091
(Publication Number WO 2010/042780),
entitled ‘‘Methods and Compositions for
Treating Status Epilepticus and Seizures
Causing Status Epilepticus’’, to
Biomedisyn Corporation with its
principal place of business at 12 Indian
Trail Road, Woodbridge, Connecticut
06525.
ADDRESSES: Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, MD 21702–5012.
FOR FURTHER INFORMATION CONTACT: For
licensing issues, Dr. Paul Mele, Office of
Research & Technology Applications,
(301) 619–6664. For patent issues, Ms.
Elizabeth Arwine, Patent Attorney, (301)
619–7808; both at telefax (301) 619–
5034.
SUPPLEMENTARY INFORMATION: Anyone
wishing to object to grant of this license
can file written objections along with
supporting evidence, if any, within 15
days from the date of this publication.
Written objections are to be filed with
the Command Judge Advocate (see
ADDRESSES).
SUMMARY:
Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, Frederick, MD 21702–
5012.
For
patent issues, Ms. Elizabeth Arwine,
Patent Attorney, (301) 619–7808. For
licensing issues, Dr. Paul Mele, Office of
Research and Technology Applications
(ORTA), (301) 619–6664, both at telefax
(301) 619–5034.
FOR FURTHER INFORMATION CONTACT:
The
invention relates to a dynamic
exoskeletal orthosis applied to the leg
below the knee, designed to compensate
for weakness, pain, and/or decreased
range of motion at the ankle.
SUPPLEMENTARY INFORMATION:
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011–14803 Filed 6–14–11; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive,
Non-Exclusive, or Partially-Exclusive
Licensing of an Invention Concerning
the Methods and Compositions for
Treating Status Epilepticus and
Seizures Causing Status Epilepticus
AGENCY:
Department of the Army, DoD.
Notice.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
ACTION:
[FR Doc. 2011–14802 Filed 6–14–11; 8:45 am]
SUMMARY:
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive,
Non-Exclusive, or Partially; Exclusive
Licensing of an Invention Concerning
the Intrepid Dynamic Exoskeletal
Orthosis
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
Announcement is made of the
availability for licensing of the
invention set forth in U.S. Provisional
Patent Application Serial No.
61/518,801, entitled ‘‘Intrepid Dynamic
Exoskeletal Orthosis (IDEO),’’ filed on
SUMMARY:
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
Announcement is made of the
availability for licensing of the
invention set forth in the PCT/US2009/
060091, entitled ‘‘Methods and
Compositions for Treating Status
Epilepticus and Seizures Causing Status
Epilepticus’’ filed on October 9, 2009.
The United States Government, as
represented by the Secretary of the
Army, has rights to this invention. U.S.
and selected foreign rights are available.
Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, MD 21702–5012.
ADDRESSES:
For
licensing issues, Dr. Paul Mele, Office of
Research & Technology Applications,
(301) 619–6664. For patent issues, Ms.
Elizabeth Arwine, Patent Attorney, (301)
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\15JNN1.SGM
15JNN1
Federal Register / Vol. 76, No. 115 / Wednesday, June 15, 2011 / Notices
619–7808, both at telefax (301) 619–
5034.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011–14801 Filed 6–14–11; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF EDUCATION
[Docket ID ED–2011–OII–0001]
Investing in Innovation Fund
Office of Innovation and
Improvement, Department of Education.
ACTION: Notice announcing the location,
dates, and times of pre-application
meetings.
AGENCY:
Overview Information
Investing in Innovation Fund
Catalog of Federal Domestic Assistance
(CFDA) Numbers: 84.411A (Scale-up grants),
84.411B (Validation grants), and 84.411C
(Development grants).
The Assistant Deputy
Secretary for Innovation and
Improvement announces preapplication meetings for the fiscal year
(FY) 2011 Investing in Innovation Fund
(i3) competition. The Department of
Education (Department) published three
notices inviting applications for the i3
program in the Federal Register on June
3, 2011 (76 FR 32148–32182). These
notices include the priorities and
selection criteria that the Department
will use for the FY 2011 i3 competition.
The Department published a separate
notice inviting applications for each
grant type—Scale-up, Validation, and
Development—under the i3 program.
FOR FURTHER INFORMATION CONTACT:
Thelma Leenhouts, U.S. Department of
Education, 400 Maryland Avenue, SW.,
Room 4W302, Washington, DC 20202–
5960. Telephone: (202) 453–7122; or by
e-mail: i3@ed.gov.
If you use a telecommunications
device for the deaf (TDD) or a text
telephone (TTY), call the Federal Relay
Service, toll free, at 1–800–877–8339.
SUPPLEMENTARY INFORMATION: The
Department intends to hold preapplication meetings designed to
provide technical assistance to
interested applicants for all three types
of i3 grants (Scale-up, Validation, and
Development). The Department will
hold two pre-application meetings on
June 17, 2011, in Washington, DC, from
9:00 a.m. to 12:30 p.m. (Eastern Time)
and from 1:30 p.m. to 5:00 p.m. (Eastern
Time). The Department will also hold
one pre-application meeting on June 24,
2011, in San Francisco, California, from
jlentini on DSK4TPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:42 Jun 14, 2011
Jkt 223001
10:00 a.m. to 2:00 p.m. (Pacific Time).
The Department will hold another preapplication meeting on June 28, 2011, in
Houston, Texas, from 10:00 a.m. to 2:00
p.m. (Central Time). Each of these four
on-site pre-application meetings will
also be transmitted live through the
Internet as a webinar. Detailed
information on the pre-application
meetings, including registration
information for the on-site meetings and
webinars, specific location information
for the on-site meetings, and
information on how to notify the
Department if an attendee will need
special accommodations, is available on
the i3 Web site at https://www2.ed.gov/
programs/innovation/.
Accessible Format: Individuals with
disabilities can obtain this document in
an accessible format (e.g., braille, large
print, audiotape, or compact disc) on
request to the program contact person
listed under FOR FURTHER INFORMATION
CONTACT.
Electronic Access to This Document:
The official version of this document is
the document published in the Federal
Register. Free Internet access to the
official edition of the Federal Register
and the Code of Federal Regulations is
available via the Federal Digital System
at: https://www.gpo.gov/fdsys. At this
site you can view this document, as well
as all other documents of this
Department published in the Federal
Register, in text or Adobe Portable
Document Format (PDF). To use PDF
you must have Adobe Acrobat Reader,
which is available free at the site.
You may also access documents of the
Department published in the Federal
Register by using the article search
feature at: https://
www.federalregister.gov. Specifically,
through the advanced search feature at
this site, you can limit your search to
documents published by the
Department.
Dated: June 10, 2011.
James H. Shelton, III,
Assistant Deputy Secretary for Innovation and
Improvement.
[FR Doc. 2011–14861 Filed 6–14–11; 8:45 am]
BILLING CODE 4000–01–P
DEPARTMENT OF ENERGY
Extension of Scoping Period for the
Northern Pass Transmission Line
Project Environmental Impact
Statement
Department of Energy.
Reopening of scoping period.
AGENCY:
ACTION:
The U.S. Department of
Energy (DOE) is reopening the public
SUMMARY:
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
34969
scoping period for the Northern Pass
Transmission Line Project
Environmental Impact Statement (EIS)
(DOE/EIS–0463). In anticipation of
additional alternative route information
being provided by Northern Pass, DOE
is reopening the scoping period. DOE
will determine the close of the scoping
period once the additional routing
information is received from Northern
Pass, and DOE will provide at least 45
days for public review and scoping
comments on any such routing
information.
DATES: The reopened public scoping
period starts with the publication of this
notice in the Federal Register and will
remain open until DOE provides further
notice of its closing.
ADDRESSES: Comments on the scope of
the EIS and requests to be added to the
document mailing list should be
addressed to: Brian Mills, Office of
Electricity Delivery and Energy
Reliability (OE–20), U.S. Department of
Energy, 1000 Independence Avenue,
SW., Washington, DC 20585; by
electronic mail to
Brian.Mills@hq.doe.gov; or by facsimile
to 202–586–8008. For general
information on the DOE NEPA process
contact: Ms. Carol M. Borgstrom,
Director, Office of NEPA Policy and
Compliance (GC–54), U.S. Department
of Energy, 1000 Independence Avenue,
SW., Washington, DC 20585; by
electronic mail at askNEPA@hq.doe.gov;
by facsimile at 202–586–7031; or by
phone at 202–586–4600, or leave a
message at 800–472–2756.
FOR FURTHER INFORMATION CONTACT: For
information on DOE’s proposed action,
contact Brian Mills by one of the
methods listed in ADDRESSES above, or
at 202–586–8267. For general
information on the DOE NEPA process,
contact Ms. Carol M. Borgstrom by one
of the methods listed in ADDRESSES
above. For information on the Forest
Service’s role as a cooperating agency,
contact Tiffany Benna by electronic mail
at tbenna@fs.fed.us; by phone at 603–
536–6241; by facsimile at 603–536–
3685; or by mail at 71 White Mountain
Drive, Campton, NH 03223. For
information on the Army Corps of
Engineers’ permit process, contact Erika
Mark at 978–318–8250; by electronic
mail at Erika.L.Mark@usace.army.mil; or
by mail at 696 Virginia Road, Concord,
MA 01742. For information on the EPA
role in the EIS, contact Timothy L.
Timmermann by electronic mail at
timmermann.timothy@epa.gov; by
phone at 617–918–1025; or by mail at 5
Post Office Square, Suite 100, Boston,
MA 02109–3912. Information on the EIS
also is available at DOE’s Web site for
E:\FR\FM\15JNN1.SGM
15JNN1
Agencies
[Federal Register Volume 76, Number 115 (Wednesday, June 15, 2011)]
[Notices]
[Pages 34968-34969]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14801]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive, Non-Exclusive, or
Partially-Exclusive Licensing of an Invention Concerning the Methods
and Compositions for Treating Status Epilepticus and Seizures Causing
Status Epilepticus
AGENCY: Department of the Army, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Announcement is made of the availability for licensing of the
invention set forth in the PCT/US2009/060091, entitled ``Methods and
Compositions for Treating Status Epilepticus and Seizures Causing
Status Epilepticus'' filed on October 9, 2009. The United States
Government, as represented by the Secretary of the Army, has rights to
this invention. U.S. and selected foreign rights are available.
ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick,
MD 21702-5012.
FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele,
Office of Research & Technology Applications, (301) 619-6664. For
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301)
[[Page 34969]]
619-7808, both at telefax (301) 619-5034.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-14801 Filed 6-14-11; 8:45 am]
BILLING CODE 3710-08-P